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Abstract
Aims: We examined differences in sickness absence in relation to at-risk drinking and abstinence,
taking into account potential changes in consumption.
Methods: We used individual-participant data (n = 46,514) from four prospective cohort studies
from Finland, France and the UK. Participants responded to a survey on alcohol use at two time
points 4–6 years apart, and were linked to records of sickness absence for an ~6-year follow-up
after the latter survey. Abstainers were those reporting no alcohol use in either survey. At-risk
drinkers at T1 were labelled as ‘former’, at-risk drinkers at T2 as ‘current’ and at-risk drinkers at
both times as ‘consistent’ at-risk drinkers. The reference group was low-risk drinkers at both times.
Study-specific analyses were stratified by sex and socioeconomic status (SES) and the estimates
were pooled using meta-analysis.
Results: Among men (n = 17,285), abstainers (6%), former (5%), current (5%) and consistent (7%)
at-risk drinkers had an increased risk of sickness absence compared with consistent low-risk drin-
kers (77%). Among women (n = 29,229), only abstainers (12%) had a higher risk of sickness
absence compared to consistent low-risk drinkers (74%). After adjustment for lifestyle and health,
abstaining from alcohol was associated with sickness absence among people with intermediate
and high SES, but not among people with low SES.
Conclusions: The U-shaped alcohol use—sickness absence association is more consistent in men
than women. Abstinence is a risk factor for sickness absence among people with higher rather
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than lower SES. Healthy worker effect and health selection may partly explain the observed
differences.
Short summary: In a pooled analysis from four cohort studies from three European countries, we
demonstrated a U-shaped association between alcohol use and sickness absence, particularly
among men. Abstinence from alcohol was associated with increased sickness absenteeism
among both sexes and across socioeconomic strata, except those with low SES.
INTRODUCTION
Sickness absence, that is absence from work due to own illness, is an
important measure of work-related functioning and a predictor of
permanent work disability and premature mortality (Kivimaki et al.,
2003, 2008; Head et al., 2008; Vahtera et al., 2004). There is grow-
ing evidence suggesting that the association between alcohol use and
sickness absence is curvilinear rather than linear with increased sick-
ness absence rates seen both among at-risk drinkers and abstainers
(Marmot et al., 1993; Upmark et al., 1999; Laaksonen et al., 2009;
Vasse et al., 1998; Vahtera et al., 2002). To date, however, few
studies have had the possibility of using repeat data on alcohol use
or examined whether the U-shaped association varies between sub-
groups (Schou and Moan, 2016).
Women may be more vulnerable to the adverse effects of at-risk
alcohol use, but empirical evidence on sex differences in relation to
sickness absence is mixed (Johansson et al., 2009; Norstrom and
Moan, 2009; Salonsalmi et al., 2009; Hensing et al., 2011; Schou
et al., 2014; Morois et al., 2017). Previous research has also estab-
lished an inverse socioeconomic gradient in both at-risk drinking
(Mackenbach et al., 2008; Johansson et al., 2009; Probst et al.,
2014) and sickness absence (Kristensen et al., 2010; Sumanen et al.,
2015), but few studies to date have examined whether the associ-
ation between alcohol use and sickness absence differs according to
socioeconomic status (SES). It has been suggested that flexible work-
ing hours and other flexible work arrangements often found in high-
er socioeconomic positions could hide the absence or inefficiency
due to hangover and, thus, weaken the association between at-risk
alcohol use and sickness absence in those groups of employees
(Schou and Moan, 2016). However, we found only one study to test
this hypothesis, suggesting that the association between alcohol con-
sumption and sickness absence may be more pronounced for low-
educated men (Johansson et al., 2009). A major limitation in all
those studies is the relatively small sample size and the scarcity of
longitudinal data on alcohol use precluding assessment of long-term
drinking patterns or the temporal order between alcohol use and
sickness absence (Schou and Moan, 2016). There are known cul-
tural differences in alcohol use (Kuendig et al., 2008; Kuntsche
et al., 2015) and international differences in sickness absence prac-
tices and social insurance systems. Thus, in order to achieve more
generalizable results, it is important to examine the alcohol use—
sickness absence association in data from multiple countries.
In this study, we examined whether the association between
alcohol use and sickness absence varies between men and women or
by SES. To address some of the limitations in previous studies, we
measured alcohol consumption repeatedly; distinguished long-term
at-risk drinking from former and current at-risk drinking, abstinence
and long-term moderate (low-risk) alcohol consumption; used longi-
tudinal data with assessments of alcohol use preceding the follow-up




Data were derived from four cohort studies: (a) a representative
population sample of Finnish working-age adults participating in
the Health and Social Support (HeSSup) study, Finland (Paljarvi
et al., 2013); (b) the Whitehall II study of government employees,
the UK (Marmot and Brunner, 2005); (c) the employees of the
national gas and electricity company of the GAZEL study, France
(Goldberg et al., 2015); and (d) the municipal employees of the
Finnish Public Sector (FPS) study, Finland (Vahtera et al., 2002).
Ethical approval for the HeSSup study was obtained from Turku
University Central Hospital Ethics committee, for Whitehall II study
from the University College London Medical School committee on
the ethics of human research, for GAZEL study from the Inserm
Ethics committee, and for FPS from the Ethics committee of the
Hospital District of Helsinki and Uusimaa.
From all four cohorts, we included respondents who were alive,
not retired before the start of the follow-up, and had data on all
studied variables from the surveys that were included in this study
design. The eligible population in each study comprised the respon-
dents of a baseline and follow-up questionnaire survey. In the
HeSSup study, the survey years were 1998 and 2003 (n = 10,511),
in the GAZEL study 1993 and 1997 (n = 6873), in the Whitehall II
study phases 1 (1985–1988) and 3 (1991–1994) (n = 4160), and in
the FPS 2000–2002 and 2004 (n = 24,970). We demonstrate the
study design in Fig. 1. The follow-up time (time at-risk for sickness
absence) in all studies was until disability or old-age pension, death
or end of sickness absence follow-up, whichever came first.
Alcohol use
Alcohol use was requested by questions on weekly consumption by
type of drink. We converted drinks/alcohol units to grams of pure
alcohol. One drink/alcohol unit was estimated as 12 g of alcohol
(=EUR unit), except in the Whitehall II study, where one unit was
estimated as 8 g (=UK unit). Alcohol intake was categorized into
‘abstainers’, ‘moderate use’ (a maximum of 140 g equalling 1–11
EUR units or 1–17 UK units for women and 280 g equalling 1–23
EUR units or 1–34 UK units for men per week), and ‘at-risk drink-
ing’ (>140 g equalling >11 EUR units or >17 UK units for women
and >280 g or >23 EUR units or >34 UK units for men per week).
The cut-points of at-risk drinking were based on the Finnish Current
Care Guidelines (Alho et al., 2015). These cut-points are not used in
the UK, where a maximum of 14 weekly units (1 unit = 8 g of pure
alcohol totalling 112 g per week) have been defined as cut-point for
moderate drinking for both sexes (Drinkaware, 2016). We per-
formed sensitivity analyses with UK’s recommended limits.
Alcohol use was measured twice (two survey responses) 4–6 years
apart, depending on the cohort (Fig. 1). Based on these two
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measurements, we classified the respondents as ‘consistent abstainers’
(no alcohol use in either survey), ‘consistent low-risk users’ (moderate
use reported in both surveys), ‘former at-risk users’ (heavy use
reported at baseline survey, but less than that in the follow-up sur-
vey), ‘consistent at-risk users’ (heavy use reported in both surveys)
and ‘current at-risk users’ (heavy use at follow-up survey only).
Sickness absence
Sickness absence was measured as the number of sickness absence days
per follow-up year. In HeSSup and FPS, register information on the
dates of sickness absence exceeding 9 days was retrieved from the
Social Insurance Institution of Finland. These data included all absence
episodes lasting for at least 10 days, from the date that illness began
(the first day of absence from work) until the sickness absence benefit
ended. The follow-up was from 1 January 2004 until 31 December
2010 in HeSSup and from 1 January 2005 until 31 December 2011 in
FPS. Neither Hessup nor FPS covered short-term sickness absences. In
Whitehall II, information on all sickness absence days, irrespective of
the length of the absence, was obtained from the Civil Service
(employer) records for those employees who gave consent to monitor
their sickness absence for a follow-up period from phase 3 until the end
of 1998. In GAZEL, the information on the total number of annual
days of sickness absence was obtained from the employer’s records for
a follow-up period from 1 January 1998 until 31 December 2004
(Fig. 1). In all countries included in this study, sickness absence benefits
are based on a physician’s certificate of diagnosed illness, which causes
work disability. In Finland, alcohol dependence does not entitle a per-
son to sickness absence benefits, but having such a condition does not
preclude benefits if there is a comorbid condition causing work disabil-
ity. In the UK and France, employees are entitled to sickness absence
benefits regardless of the cause. The sickness absence schemes and
alcohol-related practices are detailed in Supplementary Table 1.
Covariates and potential effect modifiers
Covariates, measured at T2, were SES, sex, age, smoking, body
mass index, somatic disease and psychological distress. SES and sex
were also tested as effect modifiers.
SES, divided into three groups, was based on occupational class,
except for HeSSup, where information on occupational class was
unavailable and SES was based on vocational education. In FPS and
GAZEL, SES was based on register data from employers, and in
HeSSup and Whitehall, it was based on self-reports. High SES
included administrators, managers, experts, specialists and in
HeSSup, those with university/polytechnic education. Intermediate
SES included skilled non-manual occupations, such as office work,
customer service, sales work, hospital nurses and in HeSSup, those
with college-level education. Low SES included manual workers,
such as construction workers, manufacturing, transportation, and in
HeSSup, those with vocational school, vocational course, appren-
ticeship training or no vocational education.
Information on sex and age were either from employers’ or other
registers, or self-reported. Age was treated as a continuous variable
in the analyses. Smoking and psychological distress were self-
reported in all studies. Smoking was dichotomized into current smo-
ker or non-smoker (including never and ex-smokers). Body mass
index (BMI = weight in kg divided by height in m2) was self-
reported in HeSSup, GAZEL and FPS. In the Whitehall II, BMI was
derived from measures taken at clinical examinations. BMI was
categorized as <25, 25–29 and 30 or more (obesity).
In Whitehall II and FPS studies, psychological distress was mea-
sured by the 12-item General Health Questionnaire (GHQ-12)
(Goldberg et al., 1997; Aalto et al., 2012). In the GHQ-12, respon-
dents rate the extent to which they are affected by each of the 12
symptoms (1 = not at all, 2 = as much as usual, 3 = slightly more
than usual, 4 = much more than usual). Participants with a rating of
3 or 4 in at least four items of the total measure were coded as cases
of psychological distress. In GAZEL, we used the Emotional
Reaction scale from the Nottingham Health Profile (NHP) measured
in 1995 (Bucquet et al., 1990). The NHP Emotional Reaction scale
has nine items, which are weighted to indicate their perceived sever-
ity (range 0–100). Higher scores indicate higher dysfunction. We
coded upper quartile values as cases of psychological distress, to
which we added respondents reporting depression in 1997 (even if
they were not cases in 1995). In HeSSup, we used Beck’s Depression
Inventory to identify psychological distress (Aalto et al., 2012;
Kliem et al., 2014). Those with moderate to severe depression were
coded as cases for psychological distress, and those with minimal to
mild as non-cases.
In HeSSup and FPS, somatic chronic disease were chronic stage
2 hypertension, coronary artery disease, diabetes, asthma or chronic
obstructive pulmonary disease, rheumatoid arthritis and cancer. In
GAZEL and Whitehall II, the list also included stroke. These data
were register-based in FPS and HeSSup, from clinical examinations
and self-reports in Whitehall II, and self-reported in GAZEL.
Statistical analysis
We used a two-stage meta-analysis (Riley et al., 2010). In the first
stage, we used negative binomial regression analysis to examine the
rate ratios (RR with their 95% confidence intervals [CI]) of sickness
absence for no alcohol use, former at-risk drinking, and consistent
at-risk drinking, compared to consistent low-risk drinking. We fur-
ther stratified these data by sex and SES. All models were adjusted
Fig. 1. Timeline and study design in each cohort. T1 and T2 mark the two surveys. Follow-up time for sickness absence is indicated by dotted lines.
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for sex and SES (where applicable), and age, smoking, BMI, somatic
disease, and psychological distress. The study-specific results were
analysed using SAS 9.4 (Cary, NC).
In the second stage of the meta-analysis, study-specific estimates
were pooled in fixed effects meta-analysis with Stata 13 software.
We examined heterogeneity between the estimates using the I2 statis-
tic. We conducted metaregression to identify heterogeneity of effect
by sex and SES, i.e. test effect modifications.
RESULTS
In HeSSup, 78% of the respondents were classified as consistent
low-risk drinkers, 9% as consistent abstainers, 3% as former at-risk
drinkers, 3% as consistent at-risk drinkers and 5% as current at-
risk drinkers. The corresponding percentages were 69, 7, 6, 12 and
6 for GAZEL; 76, 12, 4, 5 and 3 for Whitehall II; and 75, 10, 4, 6
and 5 for FPS. Consistent at-risk drinkers were the oldest in all
cohorts except for Whitehall II, where abstainers were the oldest.
Abstainers were more often women and had low SES. In Whitehall,
chronic somatic disease was most prevalent among abstainers,
whereas in other cohorts, the differences were smaller. Psychological
distress was linked with at-risk drinking in all cohorts except in
GAZEL, where it was linked with abstaining from alcohol. Smoking
was associated with at-risk drinking in all cohorts. Abstainers had
the highest observed (unadjusted) mean of annual sickness absence
days per person-year in GAZEL (14 days), Whitehall II (15 days)
and FPS (13 days) whereas in HeSSup, highest mean was among
consistent at-risk drinkers (10 days). The mean follow-up time was
shortest in GAZEL (3.1–3.7 years), and longest in HeSSup and FPS
(5.9–6.7 years) (Table 1).
Risk of sickness absence by alcohol use
Figure 2 shows the results on sickness absence in each cohort and the
pooled estimates according to alcohol use and compared with consistent
low-risk drinking (pooled n = 34,884 [75%]). Abstainers had a higher
risk of sickness absence (pooled RR = 1.30, 95% CI: 1.20–1.40). Also
former at-risk drinkers (RR = 1.19, 95% CI: 1.07–1.33) and current
at-risk drinkers (RR = 1.13, 95% CI: 1.02–1.26) had a higher risk of
sickness absence compared with consistent low-risk drinkers, but
consistent at-risk drinkers did not have a higher risk of sickness
absence (pooled RR = 1.05, 95% CI: 0.95–1.15) compared with
consistent low-risk drinkers. Within groups of alcohol use, signifi-
cant heterogeneity was observed between the studies among cur-
rent at-risk drinkers (I2 = 82%, P = 0.001) and consistent at-risk
drinkers (I2 = 67%, P = 0.03). Overall, there was significant
heterogeneity between groups of alcohol use (P = 0.005, metare-
gression P = 0.09), and the overall between-study heterogeneity
was high (I2 = 63%, P < 0.001).
When using UK-recommended cut-point of at-risk drinking, only
abstainers (RR = 1.29, 95% CI: 1.20–1.39) and former at-risk drinkers
(RR = 1.15, 95% CI: 1.05–1.26) had a higher risk of sickness absence
compared to consistent low-risk drinkers (Supplementary Fig. 1).
Sex-stratified analysis
We then performed the analyses stratified by sex (metaregression P
for sex interaction = 0.02). The association with absenteeism
between both abstinence and at-risk drinking were stronger among
men than women. Figure 3a shows the results among men compar-
ing the risk among abstainers and at-risk drinkers with consistent
low-risk drinking (pooled n = 13,389 [77%]). Among men,
abstaining and all types of at-risk drinking were associated with a
higher risk of sickness absence. No significant heterogeneity was
observed between groups of alcohol use (P = 0.28; metaregression
P = 0.42), but the overall between-study I2 value was 54%, P =
0.006. Significant heterogeneity between the studies was observed
for consistent (I2 = 76%, P = 0.006) and current at-risk drinking
(I2 = 75%, P = 0.007).
Figure 3, Panel b shows the results among women comparing
the risk of sickness absence among abstainers and at-risk drinkers
with consistent low-risk drinking (pooled n = 13,389 [77%]).
Among women, only abstaining (RR = 1.24, 95% CI: 1.14–1.34)
was associated with a higher risk of sickness absence. The estimates
in each group of alcohol use differed from each other (heterogeneity
between groups P = 0.001; metaregression P = 0.003), and there
was also considerable heterogeneity between the studies (overall
I2 = 54%, P = 0.006). Within groups of alcohol use, significant het-
erogeneity between the studies was observed for former at-risk
drinking women (I2 = 63%, P = 0.04). The results were largely
similar when using UK-recommended cut-point of at-risk drinking,
as shown in Supplementary Fig. 2.
Socioeconomic disparities in the alcohol use—sickness
absence association
Next, we studied the alcohol use—sickness absence association
stratified by SES (metaregression for effect modification by SES P =
0.87). Among people with low SES (n = 8613), alcohol use was not
associated with sickness absence either among abstainers or at-risk
drinkers compared with low-risk drinkers, as shown in Fig. 4a.
There was no heterogeneity between groups of alcohol use (P =
0.83, metaregression P = 0.39), and no heterogeneity between the
studies among people with low SES (overall I2 = 0%, P = 0.58).
As shown in Fig. 4b, differences between groups of alcohol use
were observed among people with intermediate SES (n = 15,720).
Among them, abstainers (RR = 1.41, 95% CI: 1.26–1.57) and for-
mer at-risk drinkers (RR = 1.36, 95% CI: 1.16–1.61) had a higher
risk of sickness absence than low-risk drinkers, whereas consistent
or current at-risk drinking were not associated with sickness
absence. We observed significant heterogeneity between groups of
alcohol use (P = 0.004), which was confirmed with metaregression
(P = 0.007). There was significant between-study heterogeneity
among people with intermediate SES (overall I2 = 47%, P = 0.02).
Among people with high SES (n = 22,181), abstainers had a
higher risk of sickness absence than consistent low-risk drinkers
(RR = 1.28, 95% CI: 1.11–1.47), without heterogeneity between
studies (I2 = 0%, P = 0.66). The risk among all types of at-risk drin-
kers was non-significant. However, considerable between-study het-
erogeneity was observed among current at-risk drinkers (I2 = 76%,
P = 0.006) (Fig. 4c). No differences in the estimates between groups
of alcohol use were observed (heterogeneity between groups of alco-
hol use was P = 0.25, metaregression P = 0.29). Overall I2 was
47%, P = 0.02, indicating overall heterogeneity between studies
among people with high SES. The results were largely similar when
using the UK-recommended cut-point for at-risk drinking, as shown
in Supplementary Fig. 3.
The largest differences between SES groups were observed
among abstainers. Thus, we studied abstainers stratified by SES.
Supplementary Fig. 4 shows that there was marginally significant
heterogeneity between SES groups (P = 0.03; metaregression P =
0.06). Abstainers with intermediate to high SES had a higher risk of
sickness absence than those with low SES.
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Table 1. Characteristics of the four cohorts by alcohol use
HeSSup GAZEL Whitehall II FPS
No alcohol use n = 978 (9%) n = 488 (7%) n = 502 (12%) n = 2525 (10%)
Mean age (SD) 43 (10.8) 50 (3.4) 50 (5.8) 49 (8.3)
Men (%) 28 41 50 11
Women (%) 72 59 50 89
High SES (%) 23 24 13 47
Intermediate SES (%) 30 59 48 34
Low SES (%) 47 17 39 19
Chronic somatic disease (%) 13 19 40 17
Psychiatric distress (%) 3 35 26 2
Smokers (%) 14 15 14 10
BMI > 30 (%) 14 9 14 16
Mean days of sickness absence/person-year 9.0 14.3 15.2 12.6
Mean follow-up time, years (SD) 6.4 (1.5) 4.2 (2.3) 4.4 (2.5) 5.9 (1.9)
Consistent low-risk drinking n = 8236 (78%) n = 4748 (69%) n = 3146 (76%) n = 18754 (75%)
Mean age (SD) 42 (10.7) 51 (2.9) 49 (5.7) 48 (8.2)
Men (%) 44 76 78 20
Women (%) 56 24 22 80
High SES (%) 33 43 46 58
Intermediate SES (%) 32 49 44 28
Low SES (%) 35 9 10 14
Chronic somatic disease (%) 11 17 31 15
Psychiatric distress (%) 3 26 27 24
Smokers (%) 19 16 12 14
BMI > 30 (%) 11 8 8 12
Mean days of sickness absence/person-year 6.4 8.3 7.0 9.9
Mean follow-up time, years (SD) 6.5 (1.2) 3.7 (2.2) 4.5 (2.5) 6.2 (1.7)
Former at-risk drinking n = 431 (3%) n = 422 (6%) n = 175 (4%) n = 1019 (4%)
Mean age (SD) 40 (11.5) 51 (2.8) 48 (5.4) 47 (8.4)
Men (%) 30 81 73 20
Women (%) 70 19 27 80
High SES (%) 29 42 47 58
Intermediate SES (%) 32 50 44 27
Low SES (%) 39 8 9 15
Chronic somatic disease (%) 14 18 35 19
Psychiatric distress (%) 4 28 34 29
Smokers (%) 33 21 22 26
BMI > 30 (%) 13 10 10 15
Mean days of sickness absence/person-year 7.8 9.1 8.4 11.7
Mean follow-up time, years (SD) 6.6 (1.2) 3.5 (2.2) 4.4 (2.3) 6.2 (1.7)
Consistent at-risk drinking n = 352 (3%) n = 791 (12%) n = 199 (5%) n = 1382 (6%)
Mean age (SD) 46 (9.0) 52 (2.6) 48 (5.2) 50 (7.2)
Men (%) 34 85 73 23
Women (%) 66 15 27 77
High SES (%) 30 38 38 65
Intermediate SES (%) 33 51 57 22
Low SES (%) 38 11 5 13
Chronic somatic disease (%) 13 19 38 19
Psychiatric distress (%) 7 25 30 29
Smokers (%) 39 31 30 25
BMI > 30 (%) 12 9 11 17
Mean days of sickness absence/person-year 9.9 8.7 9.8 11.4
Mean follow-up time, years (SD) 6.4 (1.4) 3.1 (2.1) 4.6 (2.3) 6.1 (1.7)
Current at-risk drinking n = 514 (5%) n = 424 (6%) n = 138 (3%) n = 1290 (5%)
Mean age (SD) 42 (9.3) 51 (3.0) 47 (5.1) 47 (7.9)
Men (%) 31 78 75 19
Women (%) 69 22 25 81
High SES (%) 27 42 51 59
Intermediate SES (%) 35 46 43 27
Low SES (%) 38 11 6 14
Chronic somatic disease (%) 10 22 32 16
Psychiatric distress (%) 5 26 24 30
Continued
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DISCUSSION
In this pooled analysis of individual-level data from four cohorts in
three European countries, we found evidence of a U-shaped associ-
ation between the level of alcohol use and sickness absence among
men, which was independent of age, SES, health behaviours and
psychiatric and somatic morbidity. Among women, abstainers had a
higher risk of sickness absence than consistent low-risk drinkers.
Moreover, we observed more differences between groups of alcohol
use among people with intermediate to high SES than low SES.
Our findings add to previous evidence regarding an increased
risk of sickness absence among abstainers compared with consistent
low-risk drinkers (Marmot et al., 1993; Upmark et al., 1999;
Laaksonen et al., 2009; Vasse et al., 1998; Vahtera et al., 2002).
There is biochemical and observational evidence suggesting benefi-
cial effects of moderate alcohol use on cardiovascular disease mor-
tality (Poikolainen et al., 2005; Edelman and Fiellin, 2016; Roerecke
and Rehm, 2012). Our study lends support for this hypothesis in
relation to sickness absence, although we were only able to ascertain
abstinence during the preceding 4–6 years rather than to control for
lifetime alcohol use. Thus, while we adjusted our analyses for
chronic somatic illness and mental distress at baseline, we cannot
completely rule out the hypothesis that the association between
abstaining and increased sickness absence could be due to health
selection that is the fact that these people could be former heavy
drinkers or people abstaining due to health reasons. However, our
Table 1. Continued
HeSSup GAZEL Whitehall II FPS
Smokers (%) 39 22 19 25
BMI > 30 (%) 13 9 15 13
Mean days of sickness absence/person-year 7.7 11.4 7.1 11.7
Mean follow-up time, years (SD) 6.6 (1.2) 3.6 (2.2) 4.8 (2.3) 6.3 (1.6)
SES = socioeconomic status; BMI = body mass index; SD = standard deviation.
Fig. 2. Rate ratios (95% CIs) for the association between alcohol use and sickness absence in each study cohort. Abstainers, former, consistent, and current at-risk
drinkers are compared to consistent low-risk drinkers. Adjusted for age, sex, socioeconomic status, smoking, body mass index and physical and mental morbidity.
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results correspond to an earlier study among middle-aged women,
where consistent moderate drinkers had the best self-rated health
even after controlling for chronic somatic diseases, depression and
health behaviour-related factors (Powers and Young, 2008). In that
study, consistent abstaining could be assured 8 years backwards.
There may still be genetic confounding accounting for the associ-
ation between abstaining and increased risk of sickness absence, as
suggested by a recent twin study (Ostby et al., 2016).
In the total population, while at-risk drinking at baseline (former
at-risk) or at follow-up (current at-risk) were associated with an
increased risk of sickness absence, being at-risk drinker at both
times (consistent at-risk), was not associated with sickness absence.
This may be explained by healthy worker effect, if participants to
whom consistent at-risk drinking causes health problems are
selected out from labour market, that is, if they retire early or
become unemployed. Then, the adverse health effects are not seen in
absence from work due to illness.
We found that the alcohol use—sickness absence association was
different among men and women so that at-risk drinking men had a
higher risk of sickness absence than at-risk drinking women.
Previous evidence has been rather diverse. Some studies have found
women more vulnerable (Hensing et al., 2011), some found men
more vulnerable (Norstrom, 2006; Norstrom and Moan, 2009;
Morois et al., 2017; Schou et al., 2014) and some have not found a
Fig. 3. Rate ratios (95% CIs) for the association between alcohol use and sickness absence in each study cohort among (a) men and (b) women. Consistent
abstainers, former, consistent and current at-risk drinkers are compared to consistent low-risk drinkers. Adjusted for age, socioeconomic status, smoking, body
mass index and physical and mental morbidity.
Fig. 4. Rate ratios (95% CIs) for the association between alcohol use and sickness absence in each study cohort among (a) low SES, (b) intermediate SES and
(c) high SES. Consistent abstainers, former, consistent and current at-risk drinkers are compared to consistent low-risk drinkers. Adjusted for age, sex, smoking,
body mass index and physical and mental morbidity.
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sex difference (Upmark et al., 1999; Salonsalmi et al., 2009; Vahtera
et al., 2002). Earlier studies have suggested that possible explanation
for men’s excess risk of sickness absence might be that within the at-
risk group, men have higher and more unhealthy alcohol consump-
tion than women, such as heavy episodic drinking episodes (Schou
et al., 2014). Moreover, in our main analyses, we used lower limit
of at-risk use for women than men. It is noteworthy that in general,
women have more sickness absence than men, but the contribution
of alcohol seems more pronounced among men. However, women
with alcohol use disorder have higher mortality risk than men with
alcohol use disorder (Roerecke and Rehm, 2013).
The decision to quit or reduce drinking is likely to be driven by
health impairment. In our study, men who had previously been at-
risk drinkers but had reduced their drinking, had an increased risk
of sickness absence compared to consistent low-risk drinkers. This
corresponds to a previous study in which men with former problem
drinking had a higher risk of sickness absence than men without a
history of problem drinking (Salonsalmi et al., 2015). It thus seems
that health selection plays a role in the association between reducing
alcohol intake and sickness absence, at least among men.
The differences between groups of alcohol use were larger
among people with intermediate to high SES than among low SES.
Abstaining from alcohol was a particular risk factor for sickness
absence among people with intermediate to high SES, but not
among those with low SES. Thus, our study with medically certified
all-cause sickness absence, did not support the hypothesis that high-
er socioeconomic position would hide alcohol-related absenteeism
(Schou and Moan, 2016). Future studies should examine this is
greater detail with shorter-term absences.
Our study has several strengths including a prospective design,
measuring alcohol use twice over time allowing us to assess change,
and reliable register-based sickness absence data. In earlier studies
with a single-point measurement of alcohol use, those who have
been at-risk drinkers for a long time cannot be separated from those
who have been at-risk drinkers for a short time only. To strengthen
the design, we separated current and consistent at-risk drinkers,
among whom the health consequences of drinking should be empha-
sized. To our knowledge, only one previous study has used repeated
measures of alcohol use in studying sickness absences (Salonsalmi
et al., 2015). We were also able to control for many confounding
factors, such as lifestyle and morbidity. There is a strong link
between alcohol and many non-communicable diseases, where these
diseases are causally affected by alcohol (Rehm et al., 2009; Parry
et al., 2011). By controlling for (some of) these diseases, we were
able to show that the U-shaped association between alcohol and
sickness absence observed among men was not totally due to the
overrepresentation of chronically ill employees in some groups of
alcohol use.
As to the limitations, our analyses did not adjust for physical or
psychosocial work environment. We, however, adjusted for SES
which can be considered a proxy for physical as well as psychosocial
work environment. Furthermore, previous studies have found that
psychosocial work environment contributes little to the association
between alcohol use and sickness absence (Vasse et al., 1998;
Salonsalmi et al., 2009). Another limitation is that we used self-
reported alcohol use, which is often an underestimate (Vahtera
et al., 2002; Laaksonen et al., 2009). The found associations could
thus be underestimated if actual at-risk drinkers were included in
low-risk group. As our results were robust to different cut-points of
at-risk drinking, we find this kind of bias unlikely. A further limita-
tion was that we were unable to differentiate between lifelong
abstainers and current abstainers. In a previous study from FPS
data, both lifetime and current absenteeism were linked with higher
risk of sickness absence (Vahtera et al., 2002). Finally, we had no
information on short-term absence episodes in the two Finnish
cohort studies, which may have caused some between-study hetero-
geneity. We observed significant between-study heterogeneity for
current and consistent at-risk drinkers, particularly among men and
people with high SES. This may decrease the strength of evidence in
terms of generalizability across different cultural norms and sickness
absence compensation procedures. However, no significant hetero-
geneity in study-specific estimates was observed for abstinence and
sickness absence.
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